Skip to main content

Advertisement

Log in

Bone mineral density and risk of postmenopausal breast cancer

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

To determine if higher bone mineral density (BMD) is a risk factor for breast cancer in women age 50 years and older. 37,860 women ≥50-year old with no previous breast cancer diagnosis had baseline BMD assessment between January 1999 and December 2007. Cox proportional hazards models were created for time to a new breast cancer as a function of lumbar spine or femoral neck BMD quartile (1st = lowest as reference) with adjustment for relevant covariates. A secondary analysis was performed to look for an association with estrogen receptor-positive (ER-positive) breast cancers. 794 invasive and in situ breast cancers (484 ER-positive) occurred with a median follow up of 5.4 years. Increased breast cancer risk was seen for the 3rd and 4th quartiles of lumbar spine BMD with hazard ratios (HRs) of 1.26 (95% CI, 1.01–1.58) and 1.45 (95% CI, 1.16–1.81), respectively and for the 3rd quartile of femoral neck BMD with a HR of 1.33 (95% CI, 1.07–1.64). A test for linear trend showed that lumbar spine BMD (P < 0.001) and femoral neck BMD (P = 0.04) were associated with increased risk. Higher lumbar spine BMD was also associated with increased risk of ER-positive breast cancer with HR of 1.45 (95% CI, 1.08–1.94), and 1.68 (95% CI, 1.24–2.27) for women in the 2nd and 4th quartiles, respectively. A test for linear trend showed lumbar spine BMD was associated with increasing risk of ER-positive breast cancer (P = 0.003). Increased ER-positive breast cancer risk was seen for the 3rd quartile of femoral neck BMD with a HR of 1.43 (95% CI, 1.08–1.89). Higher lumbar spine and femoral neck BMD are associated with higher risk of breast cancer in women ≥50-year old. Lumbar spine and femoral neck BMD are associated with increased risk of ER-positive breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bray F, McCarron P, Parkin DM (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6(6):229–239

    Article  PubMed  Google Scholar 

  2. American Cancer Society: cancer facts and figures. http://www.cancer.org

  3. Cummings SR, Duong T, Kenyon E et al (2002) Serum estradiol level and risk of breast cancer during treatment with raloxifene. JAMA 287(2):216–220

    Article  PubMed  CAS  Google Scholar 

  4. Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333

    Article  PubMed  CAS  Google Scholar 

  5. Bernstein L (2002) Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7(1):3–15

    Article  PubMed  Google Scholar 

  6. Cauley JA, Gutai JP, Kuller LH et al (1988) Endogenous estrogen levels and calcium intake in postmenopausal women: relationships with cortical bone measures. JAMA 260(21):3150–3155

    Article  PubMed  CAS  Google Scholar 

  7. Felson DT, Zhang Y, Hannan MT et al (1993) The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 329(16):1141–1146

    Article  PubMed  CAS  Google Scholar 

  8. Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344(4):276–285

    Article  PubMed  CAS  Google Scholar 

  9. Santen RJ, Boyd NF, Chlebowski RT et al (2007) Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocr Relat Cancer 14(2):169–187

    Article  PubMed  Google Scholar 

  10. Tucker TC, Howe HL, Weir HK (1999) Certification for population-based cancer registries. J Regist Manag 26:24–27

    Google Scholar 

  11. Leslie WD, MacWilliam L, Lix L et al (2005) A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int 16(7):773–782

    Article  PubMed  Google Scholar 

  12. Leslie WD, Caetano PA, MacWilliam LR et al (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8:25–30

    Article  PubMed  Google Scholar 

  13. Leslie WD, Metge C (2003) Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom 6:275–282

    Article  PubMed  Google Scholar 

  14. Brown JP, Josse RG (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(10 suppl):S1–S34

    PubMed  Google Scholar 

  15. Hansen KF, Binkley N, Christian R (2005) Interobserver reproducibility of criteria for vertebral body exclusion. J Bone Miner Res 20:501–508

    Article  PubMed  Google Scholar 

  16. Leslie WD (2006) The importance of spectrum bias on bone mineral density monitoring in clinical practice. Bone 39:361–368

    Article  PubMed  Google Scholar 

  17. van der Klift M, de Laet CE, Coebergh JW et al (2003) Bone mineral density and the risk of breast cancer; the Rotterdam study. Bone 32:211–216

    Article  PubMed  Google Scholar 

  18. Buist DS, Lacroix AZ, Barlow WE et al (2001) Bone mineral density and breast cancer risk in postmenopausal women. J Clin Epidemiol 54(4):417–422

    Article  PubMed  CAS  Google Scholar 

  19. Zhang Y, Kiel DP, Kreger BE et al (1997) Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 336(9):611–617

    Article  PubMed  CAS  Google Scholar 

  20. Lucas FL, Cauley JA, Stone RA (1998) Bone mineral density and risk of breast cancer: differences by family history of breast cancer. Study of Osteoporotic Fractures Research Group. Am J Epidemiol 148(1):22–29

    PubMed  CAS  Google Scholar 

  21. Chen Z, Arendell L, Aickin M (2008) Hip bone density predicts breast cancer risk independently of Gail score. Results from the Women’s Health Initiative. Cancer 113(5):907–915

    Article  PubMed  Google Scholar 

  22. Cauley JA, Song J, Dowsett SA (2007) Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors. Breast Cancer Res Treat 102(2):181–188

    Article  PubMed  Google Scholar 

  23. Stewart A, Kumar V, Torgerson DJ et al (2005) Axial BMD, change in BMD and bone turnover do not predict breast cancer incidence in early postmenopausal women. Osteoporosis 16(12):1627–1632

    Article  CAS  Google Scholar 

  24. Kerlikowske K, Shepherd J, Creasman J et al (2005) Are breast density and bone mineral density independent risk factors for breast cancer? J Natl Cancer Inst 97:368–374

    Article  PubMed  Google Scholar 

  25. Nelson RL, Turyk M, Kim J et al (2002) Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer 2(1):22

    Article  PubMed  Google Scholar 

  26. Tremollieres FA, Pouilles JM, Laparra J et al (2008) Bone mineral density at menopause does not predict breast cancer incidence. Osteoporos Int 19(10):1497–1504

    Article  PubMed  CAS  Google Scholar 

  27. Rosenberg LU, Einarsdottir K, Friman EI et al (2006) Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 15(12):2482–2488

    Article  PubMed  CAS  Google Scholar 

  28. Burshell AL, Song J, Dowsett SA et al (2008) Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis. Curr Med Res Opin 24(3):807–813

    Article  PubMed  CAS  Google Scholar 

  29. Chlebowski RT, Kuller LH, Prentice RL (2009) Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 360:573–587

    Article  PubMed  CAS  Google Scholar 

  30. Pieta B, Samulak D, Opala T et al (2009) Women’s lifestyle and the risk of breast tumors. Eur J Gynaecol Oncol 30(2):186–189

    PubMed  CAS  Google Scholar 

  31. Jacobi CE, de Bock GH, Siegerink B, et al. (2008) Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? Breast Cancer Res Treat, May 30 (Epub ahead of print)

Download references

Acknowledgments

We are indebted to Katherine Fradette for her invaluable assistance and to Manitoba Health for providing data (HIPC No. 2007-8 56). This article has been reviewed and approved by the members of the Manitoba Bone Density Program Committee.

Disclaimers

The results and conclusions are those of the authors and no official endorsement by Manitoba Health is intended or should be inferred.

Funding

Supported by a research grant from the CancerCare Manitoba Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew L. Cooke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grenier, D., Cooke, A.L., Lix, L. et al. Bone mineral density and risk of postmenopausal breast cancer. Breast Cancer Res Treat 126, 679–686 (2011). https://doi.org/10.1007/s10549-010-1138-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-1138-y

Keywords

Navigation